Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end

Targeting IL-4/IL-13 with SAR156597 failed to demonstrate an effect on lung function decline for patients with idiopathic pulmonary fibrosis; these results are in line with the negative results of two other trials targeting IL-13 in this diseasehttp://ow.ly/J0HF30mAB3J